On January 12 this year, the company received a reply from China securities regulatory commission, approving the company's public issuance of corporate bonds with face value not exceeding 1 billion yuan. Through the efforts of the company and underwriter everbright securities for more than half a year, Huadong Medicine successfully issued and listed its corporate bonds in 2015.
The final issuance of corporate bonds of the current period totaled 1 billion yuan, with a five-year term and a coupon of 4.70 %. The issue will start on May 19 and end on May 21. On July 20, this issue of corporate bonds has been listed and traded on the centralized bidding system and comprehensive agreement trading platform of Shenzhen stock exchange. Bond referred to as "15 Huadong bonds", listing code "112247".
The successful issuance of corporate bonds will help optimize corporate debt structure and enhance short-term solvency. It is conducive to expanding the company's financing channels and promoting the company's sustainable development.
width="35">
width="35">
Our Company
